Heart attack, stroke or death associated with testosterone replacement therapies

The Food & Drug Administration has launched an investigation into the risks of testosterone replacement therapy through the use of products such as AndroGel®, AndroDerm®, Axiron®, Testim® and other testosterone treatments. Research suggests that millions of men may be at risk for a heart attack, stroke, pulmonary embolism (PE), deep vein thrombosis (DVT) or premature death by taking testosterone therapy they don’t actually need. Lawsuits related to the use of testosterone replacement therapy for so-called “Low T” which seek compensation for such injuries have already been filed in Federal District Court.

If you or a loved one has been injured by these prescription testosterone products, the experienced pharmaceutical lawyers at Eisenberg, Rothweiler, Winkler, Eisenberg & Jeck are ready to evaluate your claim. For more information, contact us at info@erlegal.com or at 877-638-0114 today.